Table 1.
Gene symbol | GenBank ID | Gene description | Mean fold changes |
---|---|---|---|
Upregulated genes | |||
Apex1 | NM_009687 | Apurinic/apyrimidinic endonuclease 1 | 2.86 |
Bag1 | NM_009736 | Bcl2-associated athanogene 1 | 2.14 |
ccng1 | NM_009831 | Cyclin G1 | 2.53 |
Cradd | NM_009950 | CASP2 and RIPK1 domain containing adaptor with death domain | 2.10 |
Gadd45a | NM_007836 | Growth arrest and DNA-damage-inducible 45 alpha | 3.36 |
Msh2 | NM_008628 | MutS homolog 2 (Escherichia coli) | 2.29 |
Pttg1 | NM_013917 | Pituitary tumour-transforming 1 | 17.85 |
Rprm | NM_023396 | Reprimo, TP53-dependent G2 arrest mediator candidate | 2.92 |
Sfn | NM_018754 | Stratifin | 5.97 |
Xrcc5 | NM_009533 | X-ray repair complementing defective repair in Chinese hamster cells 5 | 2.03 |
Downregulated genes | |||
Apaf1 | NM_009684 | Apoptotic peptidase activating factor 1 | 2.13 |
Bcl2 | NM_009741 | B-cell leukaemia/lymphoma 2 | 3.25 |
Bid | NM_007544 | BH3 interacting domain death agonist | 2.45 |
Brca1 | NM_009764 | Breast cancer 1 | 2.16 |
Cdc2a | NM_007659 | Cell division cycle 2 homolog A (Schizosaccharomyces pombe) | 2.55 |
Cdkn1a | NM_007669 | Cyclin-dependent kinase inhibitor 1A (P21) | 2.85 |
E2f1 | NM_007891 | E2F transcription factor 1 | 2.00 |
FasL | NM_010177 | Fas ligand (TNF superfamily, member 6) | 2.61 |
IL6 | NM_031168 | Interleukin 6 | 13.66 |
Myc | NM_010849 | Myelocytomatosis oncogene | 4.73 |
Pmaip1 | NM_021451 | Phorbol-12-myristate-13-acetate-induced protein 1 | 2.66 |
Traf1 | NM_009421 | Tnf receptor-associated factor 1 | 2.91 |
Vcan | XM_488510 | Versican | 3.19 |
wt1 | NM_144783 | Wilms tumour homolog | 2.03 |
Selected up- and downregulated transcripts of the p53 pathway in p53−/−/myo+/+ mice (fold changes over myo-Tg mice) based on a cut-off value of 2. Values are expressed as the mean of fold changes from three independent experiments.